chevron_leftBack
As of 24 April 2025, FDC Ltd. has a market cap of $823.11M USD, ranking #9142 globally and #625 in India. It ranks #886 in the Healthcare sector, and #207 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$823.11MUSD
70.24B INR
Enterprise Value
$756.23MUSD
64.53B INR
Revenue (TTM)
$243.55MUSD
20.78B INR
EBITDA (TTM)
$36.11MUSD
3.08B INR
Net Income (TTM)
$32.16MUSD
2.74B INR
EBITDA Margin
15%
Profit Margin
13%
PE Ratio
25.6
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.4% | 1.2% | 3.9% | -9.7% | -20% | -4.1% |
Upcoming Earnings
Earnings Date
Fri, May 23
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
FDC
FDC Ltd
ISIN: INE258B01022
Shares Out.:
Shares Outstanding:
162.81M1
Shares Float:
49.044M2
|
436.20 INR | |
|
531599
(FDC)
FDC Ltd
ISIN: INE258B01022
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
430.25 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About FDC Ltd.
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.
